These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8060755)

  • 21. Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
    Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Distefano M; D'Andrea G; De Vincenzo R; Maneschi F; Ranelletti FO; Mancuso S
    Int J Cancer; 1994 Jan; 56(1):26-30. PubMed ID: 8262674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
    Dai D; Kumar NS; Wolf DM; Leslie KK
    Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steroid hormone receptor content and lymph node status in endometrial cancer.
    Morris PC; Anderson JR; Anderson B; Buller RE
    Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of placental protein 14 by the new endometrial cancer cell line MFE-280 in vitro and by endometrial carcinomas in vivo.
    Hackenberg R; Loos S; Nia AH; Kunzmann R; Schulz KD
    Anticancer Res; 1998; 18(2A):1153-8. PubMed ID: 9615781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of sex hormones receptors in leiomyoma with uncertain potential of malignancy and endometrial leiomyosarcoma: differentiatial diagnosis and prognostic significance].
    Abdalian AM; Bobrov IP; Klimachev VV; Chechulin MN; Lazarev AF
    Vopr Onkol; 2011; 57(6):742-7. PubMed ID: 22416391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.
    Bonneterre J; Hutt E; Bosq J; Graham JD; Powell MA; Leblanc E; Fujiwara K; Herzog TJ; Coleman RL; Clarke CL; Gilles EM; Zukiwski AA; Monk BJ
    Gynecol Oncol; 2015 Sep; 138(3):663-7. PubMed ID: 26142884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on expression of PCNA and estrogen, progesterone receptors in endometrial carcinoma].
    Chen YP; Shen M; Chen C
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):123-5. PubMed ID: 12536641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas.
    Staebler A; Sherman ME; Zaino RJ; Ronnett BM
    Am J Surg Pathol; 2002 Aug; 26(8):998-1006. PubMed ID: 12170086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between receptor status and results of treatment in endometrial carcinoma].
    Baĭnazarova AA; Iskakova ZhK
    Vopr Onkol; 2006; 52(6):654-8. PubMed ID: 17338243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of steroid hormone receptors for 5-year survival in stage II endometrial cancer.
    Friberg LG; Norén H
    Cancer; 1993 Jun; 71(11):3570-4. PubMed ID: 8490906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal aspects of endometrial cancer.
    Sutton G
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):69-73. PubMed ID: 2102309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer].
    Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M
    Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Estrogen and progesterone receptors in endometrial carcinoma].
    Guo Y; Dang Q
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of steroid hormone receptors in endometrial cancer].
    Kedzia W
    Ginekol Pol; 1996 May; 67(5):254-8. PubMed ID: 8925997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidermal growth factor receptors and their ligands in endometrial carcinoma: correlation with clinico-morphologic factors and steroid receptors].
    Gershtein ES; Bocharova LB; Ermilova VD; Laktionov KP; Kushlinskiĭ
    Vopr Onkol; 2000; 46(2):180-6. PubMed ID: 10853417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progestogenic effects of tibolone on human endometrial cancer cells.
    Blok LJ; De Ruiter PE; Kühne EC; Hanekamp EE; Grootegoed JA; Smid-Koopman E; Gielen SC; De Gooyer ME; Kloosterboer HJ; Burger CW
    J Clin Endocrinol Metab; 2003 May; 88(5):2327-34. PubMed ID: 12727992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma.
    Guo T; Li B; Gu C
    J BUON; 2013; 18(2):465-70. PubMed ID: 23818363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium.
    Bigsby RM; Li AX; Bomalaski J; Stehman FB; Look KY; Sutton GP
    Obstet Gynecol; 1992 Jan; 79(1):95-100. PubMed ID: 1345772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mathematical evaluation of prognostic significance of clinico-morphological and immunohistochemical features of endometrioid adenocarcinoma].
    Razorenova TS; Samsonova EA; Pozharisskiĭ KM; Razorenov GI
    Vopr Onkol; 2007; 53(6):682-9. PubMed ID: 18416138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Degree of DNA ploidy and steroid hormone receptors as prognostic factors in endometrial carcinoma].
    Köhler U; Martin R; Krug H; Bilek K
    Zentralbl Gynakol; 1991; 113(20):1086-95. PubMed ID: 1746194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.